サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1756580

破傷風トキソイドワクチンの世界市場 2025年～2029年

Global Tetanus Toxoid Vaccine Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 200 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
破傷風トキソイドワクチンの世界市場 2025年～2029年
出版日: 2025年06月18日
発行: TechNavio
ページ情報: 英文 200 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

破傷風トキソイドワクチン市場は2024年～2029年に13億3,730万米ドル、予測期間中のCAGRは4.6%で成長すると予測されます。

当レポートでは、破傷風トキソイドワクチン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ライセンス契約、破傷風、ジフテリア、百日咳の症例の増加、ワクチン接種と予防接種に関する政府のイニシアチブの増加によって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 4.4%
CAGR 4.6%
増分額 13億3,730万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間における破傷風トキソイドワクチン市場の成長を促進する主な要因の一つとして、新製品の発売を挙げています。また、予防接種キャンペーンの増加や臨床試験の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024年～2029年

第5章 市場規模実績

  • 破傷風トキソイドワクチンの世界市場 2019年～2023年
  • 年齢層別セグメント分析 2019年～2023年
  • 薬物クラス別セグメント分析 2019年～2023年
  • エンドユーザー別セグメント分析 2019年～2023年
  • 地域別セグメント分析 2019年～2023年
  • 国別セグメント分析 2019年～2023年

第6章 定性分析

  • AIの影響：破傷風トキソイドワクチンの世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：年齢層別

  • 市場セグメント
  • 比較：年齢層別
  • 新生児：市場規模と予測 2024年～2029年
  • 大人：市場規模と予測 2024年～2029年
  • 市場機会：年齢層別

第9章 市場セグメンテーション：薬剤クラス別

  • 市場セグメント
  • 比較：薬剤クラス別
  • 組み合わせ：市場規模と予測 2024年～2029年
  • 一価破傷風トキソイド：市場規模と予測 2024年～2029年
  • 市場機会：薬剤クラス別

第10章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • 病院：市場規模と予測 2024年～2029年
  • 専門クリニック：市場規模と予測 2024年～2029年
  • 公衆衛生機関：市場規模と予測 2024年～2029年
  • 外来診療センター：市場規模と予測 2024年～2029年
  • 市場機会：エンドユーザー別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024年～2029年
  • 欧州：市場規模と予測 2024年～2029年
  • アジア：市場規模と予測 2024年～2029年
  • 世界のその他の地域：市場規模と予測 2024年～2029年
  • 米国：市場規模と予測 2024年～2029年
  • ドイツ：市場規模と予測 2024年～2029年
  • 英国：市場規模と予測 2024年～2029年
  • 中国：市場規模と予測 2024年～2029年
  • フランス：市場規模と予測 2024年～2029年
  • イタリア：市場規模と予測 2024年～2029年
  • カナダ：市場規模と予測 2024年～2029年
  • メキシコ：市場規模と予測 2024年～2029年
  • スペイン：市場規模と予測 2024年～2029年
  • 日本：市場規模と予測 2024年～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Actiza Pharmaceutical Pvt. Ltd.
  • AJ Vaccines AS
  • Avalon Pharma Pvt. Ltd.
  • Bharat Biotech Ltd.
  • CSL Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Incepta Vaccine Ltd.
  • Meiji Holdings Co. Ltd.
  • Merck and Co. Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Age Group
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Tetanus Toxoid Vaccine Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Age Group - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Age Group - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Age Group
  • Exhibits41: Data Table on Comparison by Age Group
  • Exhibits42: Chart on Neonatals - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Neonatals - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Neonatals - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Neonatals - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Adults - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Adults - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Adults - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Adults - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Market opportunity by Age Group ($ million)
  • Exhibits51: Data Table on Market opportunity by Age Group ($ million)
  • Exhibits52: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits53: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits54: Chart on Comparison by Drug Class
  • Exhibits55: Data Table on Comparison by Drug Class
  • Exhibits56: Chart on Combination - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Combination - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Combination - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Combination - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on Monovalent tetanus toxoid - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Monovalent tetanus toxoid - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Monovalent tetanus toxoid - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Monovalent tetanus toxoid - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Market opportunity by Drug Class ($ million)
  • Exhibits65: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits66: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits67: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits68: Chart on Comparison by End-user
  • Exhibits69: Data Table on Comparison by End-user
  • Exhibits70: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits71: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits72: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits73: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits74: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Public health agencies - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Public health agencies - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Public health agencies - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Public health agencies - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Ambulatory care centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Ambulatory care centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Ambulatory care centers - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Ambulatory care centers - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Market opportunity by End-user ($ million)
  • Exhibits87: Data Table on Market opportunity by End-user ($ million)
  • Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits91: Chart on Geographic comparison
  • Exhibits92: Data Table on Geographic comparison
  • Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Market opportunity By Geographical Landscape ($ million)
  • Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits151: Impact of drivers and challenges in 2024 and 2029
  • Exhibits152: Overview on criticality of inputs and factors of differentiation
  • Exhibits153: Overview on factors of disruption
  • Exhibits154: Impact of key risks on business
  • Exhibits155: Companies covered
  • Exhibits156: Company ranking index
  • Exhibits157: Matrix on companies position and classification
  • Exhibits158: Actiza Pharmaceutical Pvt. Ltd. - Overview
  • Exhibits159: Actiza Pharmaceutical Pvt. Ltd. - Product / Service
  • Exhibits160: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
  • Exhibits161: SWOT
  • Exhibits162: AJ Vaccines AS - Overview
  • Exhibits163: AJ Vaccines AS - Product / Service
  • Exhibits164: AJ Vaccines AS - Key offerings
  • Exhibits165: SWOT
  • Exhibits166: Avalon Pharma Pvt. Ltd. - Overview
  • Exhibits167: Avalon Pharma Pvt. Ltd. - Product / Service
  • Exhibits168: Avalon Pharma Pvt. Ltd. - Key offerings
  • Exhibits169: SWOT
  • Exhibits170: Bharat Biotech Ltd. - Overview
  • Exhibits171: Bharat Biotech Ltd. - Product / Service
  • Exhibits172: Bharat Biotech Ltd. - Key offerings
  • Exhibits173: SWOT
  • Exhibits174: CSL Ltd. - Overview
  • Exhibits175: CSL Ltd. - Business segments
  • Exhibits176: CSL Ltd. - Key news
  • Exhibits177: CSL Ltd. - Key offerings
  • Exhibits178: CSL Ltd. - Segment focus
  • Exhibits179: SWOT
  • Exhibits180: Emergent BioSolutions Inc. - Overview
  • Exhibits181: Emergent BioSolutions Inc. - Product / Service
  • Exhibits182: Emergent BioSolutions Inc. - Key offerings
  • Exhibits183: SWOT
  • Exhibits184: GlaxoSmithKline Plc - Overview
  • Exhibits185: GlaxoSmithKline Plc - Business segments
  • Exhibits186: GlaxoSmithKline Plc - Key news
  • Exhibits187: GlaxoSmithKline Plc - Key offerings
  • Exhibits188: GlaxoSmithKline Plc - Segment focus
  • Exhibits189: SWOT
  • Exhibits190: Incepta Vaccine Ltd. - Overview
  • Exhibits191: Incepta Vaccine Ltd. - Product / Service
  • Exhibits192: Incepta Vaccine Ltd. - Key offerings
  • Exhibits193: SWOT
  • Exhibits194: Meiji Holdings Co. Ltd. - Overview
  • Exhibits195: Meiji Holdings Co. Ltd. - Business segments
  • Exhibits196: Meiji Holdings Co. Ltd. - Key offerings
  • Exhibits197: Meiji Holdings Co. Ltd. - Segment focus
  • Exhibits198: SWOT
  • Exhibits199: Merck and Co. Inc. - Overview
  • Exhibits200: Merck and Co. Inc. - Business segments
  • Exhibits201: Merck and Co. Inc. - Key news
  • Exhibits202: Merck and Co. Inc. - Key offerings
  • Exhibits203: Merck and Co. Inc. - Segment focus
  • Exhibits204: SWOT
  • Exhibits205: Panacea Biotec Ltd. - Overview
  • Exhibits206: Panacea Biotec Ltd. - Product / Service
  • Exhibits207: Panacea Biotec Ltd. - Key news
  • Exhibits208: Panacea Biotec Ltd. - Key offerings
  • Exhibits209: SWOT
  • Exhibits210: Pfizer Inc. - Overview
  • Exhibits211: Pfizer Inc. - Product / Service
  • Exhibits212: Pfizer Inc. - Key news
  • Exhibits213: Pfizer Inc. - Key offerings
  • Exhibits214: SWOT
  • Exhibits215: Sanofi SA - Overview
  • Exhibits216: Sanofi SA - Business segments
  • Exhibits217: Sanofi SA - Key news
  • Exhibits218: Sanofi SA - Key offerings
  • Exhibits219: Sanofi SA - Segment focus
  • Exhibits220: SWOT
  • Exhibits221: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibits222: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibits223: Serum Institute of India Pvt. Ltd. - Key offerings
  • Exhibits224: SWOT
  • Exhibits225: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
  • Exhibits226: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
  • Exhibits227: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
  • Exhibits228: SWOT
  • Exhibits229: Inclusions checklist
  • Exhibits230: Exclusions checklist
  • Exhibits231: Currency conversion rates for US$
  • Exhibits232: Research methodology
  • Exhibits233: Information sources
  • Exhibits234: Data validation
  • Exhibits235: Validation techniques employed for market sizing
  • Exhibits236: Data synthesis
  • Exhibits237: 360 degree market analysis
  • Exhibits238: List of abbreviations
目次
Product Code: IRTNTR73401

The tetanus toxoid vaccine market is forecasted to grow by USD 1,337.3 mn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the tetanus toxoid vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by licensing agreements, rising cases of tetanus, diphtheria, and pertussis, and increasing government initiatives regarding vaccination and immunization.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20254.4%
CAGR4.6%
Incremental Value$1,337.3 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's tetanus toxoid vaccine market is segmented as below:

By Age Group

    • Neonatals
    • Adults

By Drug Class

    • Monovalent tetanus toxoid
    • Combination

By End-user

    • Hospitals
    • Specialty clinics
    • Public health agencies
    • Ambulatory care centers

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the new product launches as one of the prime reasons driving the tetanus toxoid vaccine market growth during the next few years. Also, increasing number of immunization campaigns and increasing clinical trials will lead to sizable demand in the market.

The report on the tetanus toxoid vaccine market covers the following areas:

    • Tetanus Toxoid Vaccine Market sizing
    • Tetanus Toxoid Vaccine Market forecast
    • Tetanus Toxoid Vaccine Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tetanus toxoid vaccine market vendors that include Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Shenzhen Kangtai Biological Products Co. Ltd.. Also, the tetanus toxoid vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Age Group
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Tetanus Toxoid Vaccine Market 2019 - 2023
    • Historic Market Size - Data Table on Global Tetanus Toxoid Vaccine Market 2019 - 2023 ($ million)
  • 5.2 Age Group segment analysis 2019 - 2023
    • Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
  • 5.3 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on global tetanus toxoid vaccine market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Age Group

  • 8.1 Market segments
    • Chart on Age Group - Market share 2024-2029 (%)
    • Data Table on Age Group - Market share 2024-2029 (%)
  • 8.2 Comparison by Age Group
    • Chart on Comparison by Age Group
    • Data Table on Comparison by Age Group
  • 8.3 Neonatals - Market size and forecast 2024-2029
    • Chart on Neonatals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Neonatals - Market size and forecast 2024-2029 ($ million)
    • Chart on Neonatals - Year-over-year growth 2024-2029 (%)
    • Data Table on Neonatals - Year-over-year growth 2024-2029 (%)
  • 8.4 Adults - Market size and forecast 2024-2029
    • Chart on Adults - Market size and forecast 2024-2029 ($ million)
    • Data Table on Adults - Market size and forecast 2024-2029 ($ million)
    • Chart on Adults - Year-over-year growth 2024-2029 (%)
    • Data Table on Adults - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Age Group
    • Market opportunity by Age Group ($ million)
    • Data Table on Market opportunity by Age Group ($ million)

9 Market Segmentation by Drug Class

  • 9.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 9.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 9.3 Combination - Market size and forecast 2024-2029
    • Chart on Combination - Market size and forecast 2024-2029 ($ million)
    • Data Table on Combination - Market size and forecast 2024-2029 ($ million)
    • Chart on Combination - Year-over-year growth 2024-2029 (%)
    • Data Table on Combination - Year-over-year growth 2024-2029 (%)
  • 9.4 Monovalent tetanus toxoid - Market size and forecast 2024-2029
    • Chart on Monovalent tetanus toxoid - Market size and forecast 2024-2029 ($ million)
    • Data Table on Monovalent tetanus toxoid - Market size and forecast 2024-2029 ($ million)
    • Chart on Monovalent tetanus toxoid - Year-over-year growth 2024-2029 (%)
    • Data Table on Monovalent tetanus toxoid - Year-over-year growth 2024-2029 (%)
  • 9.5 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 10.4 Specialty clinics - Market size and forecast 2024-2029
    • Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
    • Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • 10.5 Public health agencies - Market size and forecast 2024-2029
    • Chart on Public health agencies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Public health agencies - Market size and forecast 2024-2029 ($ million)
    • Chart on Public health agencies - Year-over-year growth 2024-2029 (%)
    • Data Table on Public health agencies - Year-over-year growth 2024-2029 (%)
  • 10.6 Ambulatory care centers - Market size and forecast 2024-2029
    • Chart on Ambulatory care centers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Ambulatory care centers - Market size and forecast 2024-2029 ($ million)
    • Chart on Ambulatory care centers - Year-over-year growth 2024-2029 (%)
    • Data Table on Ambulatory care centers - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.9 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.11 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.12 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.13 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.14 Mexico - Market size and forecast 2024-2029
    • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
    • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
    • Chart on Mexico - Year-over-year growth 2024-2029 (%)
    • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • 12.15 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 12.16 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Actiza Pharmaceutical Pvt. Ltd.
    • Actiza Pharmaceutical Pvt. Ltd. - Overview
    • Actiza Pharmaceutical Pvt. Ltd. - Product / Service
    • Actiza Pharmaceutical Pvt. Ltd. - Key offerings
    • SWOT
  • 15.5 AJ Vaccines AS
    • AJ Vaccines AS - Overview
    • AJ Vaccines AS - Product / Service
    • AJ Vaccines AS - Key offerings
    • SWOT
  • 15.6 Avalon Pharma Pvt. Ltd.
    • Avalon Pharma Pvt. Ltd. - Overview
    • Avalon Pharma Pvt. Ltd. - Product / Service
    • Avalon Pharma Pvt. Ltd. - Key offerings
    • SWOT
  • 15.7 Bharat Biotech Ltd.
    • Bharat Biotech Ltd. - Overview
    • Bharat Biotech Ltd. - Product / Service
    • Bharat Biotech Ltd. - Key offerings
    • SWOT
  • 15.8 CSL Ltd.
    • CSL Ltd. - Overview
    • CSL Ltd. - Business segments
    • CSL Ltd. - Key news
    • CSL Ltd. - Key offerings
    • CSL Ltd. - Segment focus
    • SWOT
  • 15.9 Emergent BioSolutions Inc.
    • Emergent BioSolutions Inc. - Overview
    • Emergent BioSolutions Inc. - Product / Service
    • Emergent BioSolutions Inc. - Key offerings
    • SWOT
  • 15.10 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.11 Incepta Vaccine Ltd.
    • Incepta Vaccine Ltd. - Overview
    • Incepta Vaccine Ltd. - Product / Service
    • Incepta Vaccine Ltd. - Key offerings
    • SWOT
  • 15.12 Meiji Holdings Co. Ltd.
    • Meiji Holdings Co. Ltd. - Overview
    • Meiji Holdings Co. Ltd. - Business segments
    • Meiji Holdings Co. Ltd. - Key offerings
    • Meiji Holdings Co. Ltd. - Segment focus
    • SWOT
  • 15.13 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 15.14 Panacea Biotec Ltd.
    • Panacea Biotec Ltd. - Overview
    • Panacea Biotec Ltd. - Product / Service
    • Panacea Biotec Ltd. - Key news
    • Panacea Biotec Ltd. - Key offerings
    • SWOT
  • 15.15 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.16 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 15.17 Serum Institute of India Pvt. Ltd.
    • Serum Institute of India Pvt. Ltd. - Overview
    • Serum Institute of India Pvt. Ltd. - Product / Service
    • Serum Institute of India Pvt. Ltd. - Key offerings
    • SWOT
  • 15.18 Shenzhen Kangtai Biological Products Co. Ltd.
    • Shenzhen Kangtai Biological Products Co. Ltd. - Overview
    • Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
    • Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations